US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist
  • 1.2000
  • +0.0299+2.56%
Trading May 3 11:37 ET
3.91MMarket Cap-64P/E (TTM)

Clearmind Medicine Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
(Q3)Jul 31, 2022
(Q2)Apr 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-24.50%1.38M
-0.77%4.56M
65.70%1.09M
-20.16%832.01K
-29.34%1.21M
12.22%1.83M
111.36%4.59M
-38.61%660.13K
20.10%1.04M
1,015.73%1.72M
Selling and administrative expenses
-7.14%1.16M
49.79%3.41M
410.92%832.22K
-20.01%632.88K
19.65%979.97K
-4.27%1.25M
27.37%2.28M
-136.30%-267.67K
-3.73%791.16K
432.52%819K
-General and administrative expense
-7.14%1.16M
49.79%3.41M
410.92%832.22K
-20.01%632.88K
19.65%979.97K
-4.27%1.25M
27.37%2.28M
-136.30%-267.67K
-3.73%791.16K
432.52%819K
Research and development costs
-61.29%227.48K
-50.68%1.12M
-73.27%234.61K
-20.66%199.13K
-74.08%232.52K
76.75%587.63K
492.34%2.26M
160.97%877.66K
446.90%250.97K
--896.95K
Depreciation amortization depletion
----
-46.21%26.97K
----
----
----
----
3,194.70%50.14K
----
----
----
-Depreciation and amortization
----
-46.21%26.97K
----
----
----
----
3,194.70%50.14K
----
----
----
Operating profit
24.50%-1.38M
0.77%-4.56M
-65.70%-1.09M
20.16%-832.01K
29.34%-1.21M
-12.22%-1.83M
-111.36%-4.59M
38.61%-660.13K
-20.10%-1.04M
-1,015.73%-1.72M
Net non-operating interest income expense
236.25%60.58K
503.91%42.79K
209.88%11.64K
252.10%13.06K
4.37K
18.02K
-10.59K
-10.59K
-8.58K
0
Non-operating interest income
236.25%60.58K
----
----
----
--4.37K
--18.02K
----
----
----
--0
Total other finance cost
----
-503.91%-42.79K
---11.64K
-252.10%-13.06K
----
----
--10.59K
----
--8.58K
----
Other net income (expense)
293.87%157.12K
-287.48%-1.71M
-552.40%-1.71M
507.09%380.03K
-275.83%-305.36K
-1,499.93%-81.04K
-1,610.85%-440.26K
-262.14K
-93.35K
-81.25K
Gain on sale of security
293.87%157.12K
-287.48%-1.71M
-552.40%-1.71M
507.09%380.03K
-275.83%-305.36K
-1,499.93%-81.04K
-2,121.17%-440.26K
---262.14K
---93.35K
---81.25K
Special income (charges)
----
--0
----
----
----
----
--0
----
----
----
-Less:Impairment of capital assets
----
--0
----
----
----
----
--0
----
----
----
Income before tax
38.49%-1.17M
-23.33%-6.22M
-199.33%-2.79M
61.63%-438.92K
15.79%-1.51M
-15.72%-1.9M
-129.39%-5.04M
15.27%-932.86K
-31.85%-1.14M
-1,068.56%-1.8M
Income tax
5,856.25%201.5K
-42.75%12.56K
-63.44%8.02K
-5K
6.79K
3.38K
21.94K
21.94K
0
0
Net income
27.99%-1.37M
-23.04%-6.23M
-193.29%-2.8M
62.07%-433.92K
15.41%-1.52M
-15.93%-1.9M
-130.38%-5.07M
13.28%-954.8K
-31.85%-1.14M
-1,068.56%-1.8M
Net income continuous Operations
27.99%-1.37M
-23.04%-6.23M
-193.29%-2.8M
62.07%-433.92K
15.41%-1.52M
-15.93%-1.9M
-130.38%-5.07M
13.28%-954.8K
-31.85%-1.14M
-1,068.56%-1.8M
Minority interest income
Net income attributable to the parent company
27.99%-1.37M
-23.04%-6.23M
-193.29%-2.8M
62.07%-433.92K
15.41%-1.52M
-15.93%-1.9M
-130.38%-5.07M
13.28%-954.8K
-31.85%-1.14M
-1,068.56%-1.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.99%-1.37M
-23.04%-6.23M
-193.29%-2.8M
62.07%-433.92K
15.41%-1.52M
-15.93%-1.9M
-130.38%-5.07M
13.28%-954.8K
-31.85%-1.14M
-1,068.56%-1.8M
Basic earnings per share
96.37%-0.9
73.66%-30.7892
77.66%-4.6109
93.02%-1.8106
70.72%-12.0808
36.83%-24.8
-64.35%-116.9127
25.93%-20.6357
-19.79%-25.9207
-462.89%-41.2639
Diluted earnings per share
96.37%-0.9
73.66%-30.7892
77.66%-4.6109
93.02%-1.8106
70.72%-12.0808
36.83%-24.8
-64.35%-116.9127
25.93%-20.6357
-19.79%-25.9207
-462.89%-41.2639
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022(Q3)Jul 31, 2022(Q2)Apr 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -24.50%1.38M-0.77%4.56M65.70%1.09M-20.16%832.01K-29.34%1.21M12.22%1.83M111.36%4.59M-38.61%660.13K20.10%1.04M1,015.73%1.72M
Selling and administrative expenses -7.14%1.16M49.79%3.41M410.92%832.22K-20.01%632.88K19.65%979.97K-4.27%1.25M27.37%2.28M-136.30%-267.67K-3.73%791.16K432.52%819K
-General and administrative expense -7.14%1.16M49.79%3.41M410.92%832.22K-20.01%632.88K19.65%979.97K-4.27%1.25M27.37%2.28M-136.30%-267.67K-3.73%791.16K432.52%819K
Research and development costs -61.29%227.48K-50.68%1.12M-73.27%234.61K-20.66%199.13K-74.08%232.52K76.75%587.63K492.34%2.26M160.97%877.66K446.90%250.97K--896.95K
Depreciation amortization depletion -----46.21%26.97K----------------3,194.70%50.14K------------
-Depreciation and amortization -----46.21%26.97K----------------3,194.70%50.14K------------
Operating profit 24.50%-1.38M0.77%-4.56M-65.70%-1.09M20.16%-832.01K29.34%-1.21M-12.22%-1.83M-111.36%-4.59M38.61%-660.13K-20.10%-1.04M-1,015.73%-1.72M
Net non-operating interest income expense 236.25%60.58K503.91%42.79K209.88%11.64K252.10%13.06K4.37K18.02K-10.59K-10.59K-8.58K0
Non-operating interest income 236.25%60.58K--------------4.37K--18.02K--------------0
Total other finance cost -----503.91%-42.79K---11.64K-252.10%-13.06K----------10.59K------8.58K----
Other net income (expense) 293.87%157.12K-287.48%-1.71M-552.40%-1.71M507.09%380.03K-275.83%-305.36K-1,499.93%-81.04K-1,610.85%-440.26K-262.14K-93.35K-81.25K
Gain on sale of security 293.87%157.12K-287.48%-1.71M-552.40%-1.71M507.09%380.03K-275.83%-305.36K-1,499.93%-81.04K-2,121.17%-440.26K---262.14K---93.35K---81.25K
Special income (charges) ------0------------------0------------
-Less:Impairment of capital assets ------0------------------0------------
Income before tax 38.49%-1.17M-23.33%-6.22M-199.33%-2.79M61.63%-438.92K15.79%-1.51M-15.72%-1.9M-129.39%-5.04M15.27%-932.86K-31.85%-1.14M-1,068.56%-1.8M
Income tax 5,856.25%201.5K-42.75%12.56K-63.44%8.02K-5K6.79K3.38K21.94K21.94K00
Net income 27.99%-1.37M-23.04%-6.23M-193.29%-2.8M62.07%-433.92K15.41%-1.52M-15.93%-1.9M-130.38%-5.07M13.28%-954.8K-31.85%-1.14M-1,068.56%-1.8M
Net income continuous Operations 27.99%-1.37M-23.04%-6.23M-193.29%-2.8M62.07%-433.92K15.41%-1.52M-15.93%-1.9M-130.38%-5.07M13.28%-954.8K-31.85%-1.14M-1,068.56%-1.8M
Minority interest income
Net income attributable to the parent company 27.99%-1.37M-23.04%-6.23M-193.29%-2.8M62.07%-433.92K15.41%-1.52M-15.93%-1.9M-130.38%-5.07M13.28%-954.8K-31.85%-1.14M-1,068.56%-1.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.99%-1.37M-23.04%-6.23M-193.29%-2.8M62.07%-433.92K15.41%-1.52M-15.93%-1.9M-130.38%-5.07M13.28%-954.8K-31.85%-1.14M-1,068.56%-1.8M
Basic earnings per share 96.37%-0.973.66%-30.789277.66%-4.610993.02%-1.810670.72%-12.080836.83%-24.8-64.35%-116.912725.93%-20.6357-19.79%-25.9207-462.89%-41.2639
Diluted earnings per share 96.37%-0.973.66%-30.789277.66%-4.610993.02%-1.810670.72%-12.080836.83%-24.8-64.35%-116.912725.93%-20.6357-19.79%-25.9207-462.89%-41.2639
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg